Cover Feature: Novel Vancomycin‐β‐Lactam Hybrids: Structure–Activity Relationships and Therapeutic Potential Against VISA and VRE (ChemMedChem 6/2026)

View at publisher Summarise with VIRAT
Authors: Taopeng Chang, Fang Li, Chengtao Feng, Xiaowen Wang, Dongliang Guan
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The cover illustrates a novel vancomycin–β-lactam hybrid antibiotic simultaneously targeting Lipid II and PBP on the bacterial cell membrane, thereby exerting a synergistic antibacterial effect through dual inhibition of cell wall biosynthesis. In the Research article (DOI: 10.1002/cmdc.202501084), Chengtao Feng, Xiaowen Wang, Dongliang Guan, and co-workers systematically constructed and evaluated a series of hybrid molecules, identifying the C-terminally modified compound 6a as exhibiting significantly enhanced antibacterial activity against resistant strains such as VISA and VRE. These findings provide a promising strategy for the development of next-generation antibiotics against antimicrobial resistance. The inspiration for this cover design comes from Dongliang Guan.

Fields of Study & Subjects

Antimicrobial Resistance in Staphylococcus Antibiotic Resistance in Bacteria Antimicrobial Peptides and Activities

Publication details

Journal / source
ChemMedChem
Volume
21
Issue
6
Pages
e70276
Publication date
27 March 2026
Language
EN